ADAM9 and melanoma: ADAM9 overexpression was reported in several human carcinomas, including oral [31], lung [32], breast [21, 33], stomach [34], liver [35], pancreas [36], colon [37], kidney [38], prostate [39], cervix [40], and melanoma [41], and is correlated with cancer progression and metastasis, as well as having a predictive capacity for patient survival times.